| Application no. and date | 10174985.1 (espacenet) (Federated) (European Patent Register), 20020218 | | Patent/reg. no. and date | DK/EP 2269604, 20160727 | | Publication date | 20110105 | | Priority no. and date | GB 0104072, 20010219, GB 0124957, 20011017 | | EP pub. no. and date |
EP 2269604 20110105 | | Effective date | | | Applicant/owner | Novartis Pharma AG, Lichtstrasse 35
4002 Basel, CH | | Applicant ref. no. | BT/AP/154066 | | Inventor | O'Reilly, Terence, Drahtzugstrasse 51
4057 Basel, CH,
Lane, Heidi, Jakobsweg 22
4105 Biel-Benken, CH,
Wood, Jeanette Marjorie,
In den Kleematten 18
4105 Biel-Benken BL, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/436 (2006.01) , A61K 31/475 (2006.01) , A61K 31/502 (2006.01) , A61K 31/555 (2006.01) , A61K 31/5685 (2006.01) , A61K 31/704 (2006.01) , A61K 31/7068 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Behandling af solide nyretumorer med et rapamycinderivat | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2016 00060 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
